Moboxen (Mobocertinib) 40 mg Capsules
Moboxen 40 mg (Mobocertinib) is an anti-cancer medicine used for certain types of lung cancer with a specific mutation.
Manufacturer: Everest Pharmaceuticals Ltd.. Each pack contains 60 capsules. It is used in patients with non-small cell lung cancer when the tumor has a specific EGFR change called exon 20 insertion.
Key Feature:
This is a targeted treatment, which means it works more directly and is meant only for patients whose required mutation has been confirmed by testing.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 15.03.2026
What Customers Say
No reviews yet
Your review can be the first!